The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

This achievement follows Bahrain’s landmark decision on 2 December 2023 to become the second country globally and the first ...

It is believed around 1,700 people could be eligible for the treatment, while the NHS estimates around 50 people a year will ...

The Medical University of South Carolina is expanding its access to state-supported Sickle Cell programs for “warriors,” or ...

“A groundbreaking £1.65m treatment offering a potential cure for people in England living with sickle cell disease has been approved for use on the NHS, the medicine watchdog has announced.” ...

The National Health Service (NHS) has approved a groundbreaking £1.65 million treatment for sickle cell disease in England, offering patients ...

The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...

National Director of the Sickle Cell Foundation Nigeria (SCFN), Dr. Annette Akinsete, has said that despite advancements in the treatment of sickle cell disease, not every patient requires a bone ...

A sickle cell disease “cure” is to be offered to NHS patients for the first time. The £1.65 million gene therapy called exa-cel, also known under the brand name Casgevy, uses a Nobel Prize ...

As treatment and care continues to evolve, we must ensure that people living with this disease are able to advocate for ...

In addition to the prolonged pain and suffering endured by sickle cell patients, a Washington University School of Medicine ...